GlassScriptPhysician profile
Vikram J Setlur
NPI 1750547733
$872.81
in general payments reported to CMS, 2019-2025
12 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $24.90 · 2021: $78.28 · 2022: $98.98 · 2023: $160 · 2024: $261 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $212.04 | 2024-2025 | Eylea Hd, Eylea |
| Novartis Pharmaceuticals Corporation | $199.08 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $128.62 | 2022-2024 | Cequa |
| Alcon Vision LLC | $119.11 | 2023-2024 | Rocklatan, Simbrinza |
| Bausch & Lomb Americas INC. | $77.81 | 2022-2025 | Vyzulta, Miebo, Zylet |
| Tarsus Pharmaceuticals, INC. | $30.28 | 2024 | Xdemvy |
| Apellis Pharmaceuticals, INC. | $28.59 | 2023 | Syfovre |
| Alimera Sciences, INC. | $22.58 | 2023 | Iluvien |
| Oyster Point Pharma, INC. | $22.12 | 2024 | Ryzumvi, Tyrvaya |
| Shire North American Group INC | $19.23 | 2019 | |
| Eyevance Pharmaceuticals LLC | $13.35 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikram Setlur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.